Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Angioedema
ADR ID BADD_A00232
ADR Hierarchy
10      Immune system disorders
10.01      Allergic conditions
10.01.05      Angioedemas
10.01.05.009      Angioedema
23      Skin and subcutaneous tissue disorders
23.04      Angioedema and urticaria
23.04.01      Angioedemas
23.04.01.001      Angioedema
22      Respiratory, thoracic and mediastinal disorders
22.04      Upper respiratory tract disorders (excl infections)
22.04.02      Laryngeal spasm, oedema and obstruction
22.04.02.008      Angioedema
Description Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx. [MeSH]
MedDRA Code 10002424
MeSH ID D000799
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acute angio oedema | Angio-edema | Angio-oedema | Angioedema | Angioedema of larynx | Angioneurotic edema | Angioneurotic edema, not elsewhere classified | Angioneurotic oedema | Angioneurotic oedema aggravated | Edema angioneurotic | Edema Quincke's | Edema vascular | Giant hives | Giant urticaria | Hives giant | Quincke's edema | Quincke's oedema | Urticaria giant | Angioedema aggravated | Allergic angioedema | Angioneurotic edema aggravated | Acute angio edema | Oedema angioneurotic | Oedema Quincke's | Oedema vascular | Face angioedema | Lip angioedema | Eye angioedema | Respiratory angioedema | Angioedemas | Quincke's Edema | Edema, Quincke's | Quincke Edema | Quinckes Edema | Urticaria, Giant | Giant Urticaria | Giant Urticarias | Urticarias, Giant | Angioneurotic Edema | Angioneurotic Edemas | Edema, Angioneurotic | Edemas, Angioneurotic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01433Methylprednisolone0.000288%
BADD_D01434Methylprednisolone acetate--
BADD_D01435Methylprednisolone hemisuccinate--
BADD_D01436Methylprednisolone sodium succinate--
BADD_D01442Metoclopramide--
BADD_D01443Metoclopramide hydrochloride--
BADD_D01445Metoprolol0.000091%
BADD_D01449Metronidazole0.000648%
BADD_D01457Miconazole--
BADD_D01463Mifepristone--
BADD_D01470Minocycline0.000850%
BADD_D01471Minocycline anion--
BADD_D01472Minocycline hydrochloride--
BADD_D01473Minoxidil0.000701%
BADD_D01474Mipomersen sodium--
BADD_D01475Mirabegron0.000678%
BADD_D01476Mirtazapine0.000856%
BADD_D01477Misoprostol0.002466%
BADD_D01478Mitomycin0.000224%
BADD_D01484Modafinil--
BADD_D01485Moexipril hydrochloride--
BADD_D01486Moexiprilat--
BADD_D01490Mometasone--
BADD_D01491Mometasone furoate--
BADD_D01492Mometasone furoate monohydrate--
BADD_D01496Montelukast0.000102%
BADD_D01497Montelukast sodium--
BADD_D01501Moxifloxacin0.000269%
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01503Moxonidine--
The 18th Page    First    Pre   18 19 20 21 22    Next   Last    Total 29 Pages
ADReCS-Target
ADR Term Drug Name Target